Back to results
TerminatedPhase 3

An Open-Label Crenezumab Study in Participants With Alzheimer's Disease

NCT03491150

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Shankle Clinic

Newport Beach, California, United States

+65 additional locations

View on ClinicalTrials.gov
An Open-Label Crenezumab Study in Participants With Alzheimer's Disease — TrialFind